Trending Now
Arbutus Biopharma Corporation (NASDAQ:ABUS) Announce Positive AB-729 Single Dose Results In...
Arbutus Biopharma Corporation (NASDAQ:ABUS) has announced continued positive results for the ongoing phase 1a/1b clinical study with AB-729. AB-729 is the company’s GalNAc delivered...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
The Song Remains the Same for Medical Marijuana Inc (OTCMKTS:MJNA)
Medical Marijuana Inc (OTCMKTS:MJNA) has been a consistent underperformer in the cannabis space. In fact, it’s probably worse than that. The company...
MAKE IT MODERN
LATEST REVIEWS
Sorrento Therapeutics Inc. (NASDAQ:SRNE) Secures License For Novel Antibody-Drug-Nanoparticle Albumin-Bound Immune...
Sorrento Therapeutics Inc. (NASDAQ:SRNE) has signed an exclusive license agreement with Mayo Clinic for a breakthrough tech platform. The technology can generate enhanced diversity...
MAKE IT MODERN
PERFORMANCE TRAINING
Hookipa Pharma Inc (NASDAQ: HOOK) Data Has Been Selected for the American Association for...
Hookipa Pharma Inc (NASDAQ: HOOK) stated that the American Association for Cancer Research (AACR) has selected its clinical biomarker, translational, and preclinical data for...
Market pull back, can you take it seriously ?
Yesterday's market action was tepid. We’re still treading water on extremely light volume with little to see. Most of the action has...
Invesco QQQ Trust (QQQ) bounces as hoped of easing inflation grows
After breaking below $263 in the Invesco QQQ Trust (QQQ)'s this morning, buyers were found around the $260/$261 and we’re back above...
Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX) Receives Favorable Judgment From Appellate Court in Suit Against...
Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX) has announced that the US Court of Appeals of the 11th Circuit has given a mandate requiring the District...
Nektar Therapeutics (NASDAQ:NKTR) Reports Q3 2020 Financial Results And Bempegaldesleukin Development Updates
Nektar Therapeutics (NASDAQ:NKTR) has announced its Q3 2020 financial results for the period ended September 30, 2020. At the end of the quarter, the...
MAKE IT MODERN
